935 filings
Page 10 of 47
6-K
ATHE
Alterity Therapeutics Ltd
15 Jul 21
Alterity Therapeutics Announces Publication of Data Demonstrating ATH434 is
6:07am
SC 13D/A
Life Biosciences LLC
8 Jul 21
ALTERITY THERAPEUTICS / Life Biosciences ownership change
4:21pm
6-K
ATHE
Alterity Therapeutics Ltd
6 Jul 21
Report of Foreign Private Issuer
6:17am
6-K
ATHE
Alterity Therapeutics Ltd
6 Jul 21
Report of Foreign Private Issuer
6:07am
6-K
ATHE
Alterity Therapeutics Ltd
2 Jul 21
Report of Foreign Private Issuer
8:05am
6-K
ATHE
Alterity Therapeutics Ltd
1 Jul 21
Alterity Therapeutics granted a new US patent targeting major neurodegenerative
6:03am
6-K
ATHE
Alterity Therapeutics Ltd
23 Jun 21
Report of Foreign Private Issuer
6:21am
6-K
ATHE
Alterity Therapeutics Ltd
16 Jun 21
Report of Foreign Private Issuer
9:37pm
6-K
ATHE
Alterity Therapeutics Ltd
16 Jun 21
Alterity Therapeutics to Present at the MST Access
12:00am
6-K
ATHE
Alterity Therapeutics Ltd
29 Apr 21
Appendix 4C – Q3 FY21 Quarterly Cash Flow Report
6:04am
6-K
ATHE
Alterity Therapeutics Ltd
21 Apr 21
ATH434 protects brain cells and improves motor function
6:09am
6-K
ATHE
Alterity Therapeutics Ltd
20 Apr 21
Report of Foreign Private Issuer
6:19am
6-K
ATHE
Alterity Therapeutics Ltd
10 Mar 21
Alterity CEO Dr David Stamler presents to US investors at Authorization & Additional information
6:19am
6-K
ATHE
Alterity Therapeutics Ltd
26 Feb 21
Alterity to present at the 7th International Congress of
6:07am
6-K
ATHE
Alterity Therapeutics Ltd
25 Feb 21
Results for announcement to the market
6:16am
6-K
ATHE
Alterity Therapeutics Ltd
19 Feb 21
Alterity Half Year Results and Investor Webcast Notification
6:00am
6-K
ATHE
Alterity Therapeutics Ltd
11 Feb 21
Report of Foreign Private Issuer
6:11am
6-K
ATHE
Alterity Therapeutics Ltd
10 Feb 21
Report of Foreign Private Issuer
6:03am
6-K
ATHE
Alterity Therapeutics Ltd
9 Feb 21
Alterity Therapeutics announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson’s disease clinical trials
6:09am
6-K
ATHE
Alterity Therapeutics Ltd
28 Jan 21
Appendix 4C – Q2 FY21 Quarterly Cash Flow Report
6:05am